BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32602119)

  • 41. Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    Puza CJ; Josyula S; Terando AM; Howard JH; Agnese DM; Mosca PJ; Lee WT; Beasley GM
    J Surg Oncol; 2018 Jun; 117(7):1584-1588. PubMed ID: 29513892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate.
    Knackstedt R; Couto RA; Ko J; Cakmakoglu C; Wu D; Gastman B
    Ann Surg Oncol; 2019 Oct; 26(11):3550-3560. PubMed ID: 31313036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
    Ipenburg NA; Thompson JF; Uren RF; Chung D; Nieweg OE
    Ann Surg Oncol; 2019 Sep; 26(9):2855-2863. PubMed ID: 31240588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
    J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical approach to patients with low-burden stage III melanoma: Is it time to consider conservative surgery?
    Moreno-Ramírez D; Vieira R; Kaufmann R
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):498-500. PubMed ID: 31767498
    [No Abstract]   [Full Text] [Related]  

  • 50. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    Wagner JD; Davidson D; Coleman JJ; Hutchins G; Schauwecker D; Park HM; Havlik RJ
    Ann Surg Oncol; 1999 Jun; 6(4):398-404. PubMed ID: 10379863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence Patterns and Clinical Management after a Positive Sentinel Node Biopsy in Melanoma Patients.
    de Menezes JN; Arra DASM; Lôbo MM; Pinto CAL; Lima JPSN; Silva MJB; Duprat Neto JP; Bertolli E
    Cancer Invest; 2023 Dec; 41(10):830-836. PubMed ID: 37962565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
    Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
    Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Does sentinel node biopsy (SNB) solve the problem of elective lymph node excision in malignant melanoma?].
    Göhl J; Meyer T; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1319-23. PubMed ID: 9931870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
    Scheri RP; Essner R; Turner RR; Ye X; Morton DL
    Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Guidelines for stage I to III melanoma].
    Guillot B; Dalac S; Denis M; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
    Bull Cancer; 2016 Sep; 103(9):743-52. PubMed ID: 27456259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.